Medicare Enrolled
Dr. Melissa Crawley, MD
Internal Medicine · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Crawley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crawley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Crawley
Dr. Melissa Crawley is an internal medicine specialist in San Antonio, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Crawley performed 89,887 Medicare services across 4,679 unique beneficiaries.
Between the years covered by Open Payments, Dr. Crawley received a total of $10,521 from 58 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Crawley is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 0% volume in TX
$10,521 industry payments
Medicare Practice Summary
Medicare Utilization ↗89,887
Medicare services
Top 0% in TX for internal medicine
4,679
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,914 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 25,500 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia | 15,605 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 11,700 | $0 | $5 |
| Paclitaxel chemotherapy injection | 8,034 | $0 | $8 |
| Contrast dye for imaging (iodine-based) | 5,316 | $0 | $3 |
| Immune globulin infusion (Octagam) | 4,880 | $34 | $235 |
| Denosumab injection (Prolia/Xgeva) | 2,040 | $19 | $67 |
| Dexamethasone injection (steroid) | 1,702 | $0 | $1 |
| Blood draw (venipuncture) | 1,476 | $8 | $20 |
| Comprehensive metabolic blood panel | 1,400 | $10 | $64 |
| Complete blood count (CBC) with differential | 1,345 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,250 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,130 | $0 | $24 |
| Flow cytometry, additional marker | 760 | $18 | $180 |
| Office visit, established patient (30-39 min) | 693 | $90 | $368 |
| Immunoglobulin level test | 550 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 470 | $22 | $157 |
| Lactate dehydrogenase (enzyme) level | 463 | $6 | $31 |
| Office visit, established patient (20-29 min) | 454 | $62 | $250 |
| Injection, fluorouracil, 500 mg | 426 | $2 | $13 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 336 | $84 | $1,348 |
| Administration of chemotherapy into vein, 1 hour or less | 323 | $98 | $707 |
| Ferritin level test (iron stores) | 258 | $13 | $60 |
| Iron level test | 256 | $6 | $27 |
| Iron binding capacity test | 256 | $9 | $35 |
| Measurement of immunoglobulin light chains | 202 | $17 | $60 |
| Injection, zoledronic acid, 1 mg | 171 | $6 | $431 |
| Drug injection, under skin or into muscle | 168 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 162 | $46 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 149 | $1 | $7 |
| Carcinoembryonic antigen (cea) protein level | 142 | $19 | $99 |
| Microscopic examination for white blood cells with manual cell count | 129 | $4 | $22 |
| Complete blood count (CBC), automated | 129 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 126 | $15 | $100 |
| Injection of additional new drug or substance into vein | 106 | $12 | $108 |
| Administration of chemotherapy into vein, each additional hour | 106 | $21 | $161 |
| Folic acid level test | 91 | $14 | $73 |
| Vitamin B-12 level test | 90 | $15 | $76 |
| Administration of additional new drug or substance into vein, 1 hour or less | 88 | $49 | $344 |
| Infusion, normal saline solution , 1000 cc | 74 | $2 | $19 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 70 | $20 | $128 |
| Hospital follow-up visit, low complexity | 70 | $37 | $135 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 62 | $25 | $145 |
| Red blood count automated, with additional calculations | 58 | $5 | $26 |
| Coagulation function measurement, d-dimer; quantitative | 56 | $10 | $129 |
| Prothrombin time test (blood clotting) | 49 | $4 | $30 |
| Office visit, established patient, complex (40-54 min) | 49 | $131 | $496 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 46 | $55 | $211 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 45 | $124 | $500 |
| Ct scan of chest with contrast | 44 | $48 | $821 |
| Beta-2 microglobulin (protein) level | 44 | $16 | $96 |
| New patient office visit, complex (60-74 min) | 44 | $152 | $709 |
| Hospital follow-up visit, moderate complexity | 44 | $59 | $247 |
| Unclassified drugs | 44 | $1 | $8 |
| PSA test (prostate cancer screening) | 42 | $18 | $94 |
| Administration of additional new drug or substance into vein using push technique | 38 | $41 | $289 |
| New patient office visit (45-59 min) | 37 | $118 | $565 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 35 | $15 | $94 |
| CT scan of abdomen and pelvis with contrast | 33 | $161 | $1,067 |
| Infusion into a vein for hydration, 31-60 minutes | 33 | $24 | $256 |
| Thyroid stimulating hormone (TSH) test | 32 | $16 | $80 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 32 | $272 | $2,762 |
| Protein measurement, serum | 31 | $10 | $99 |
| Flow cytometry technique for dna or cell analysis, first marker | 31 | $54 | $298 |
| Sed rate test (inflammation marker) | 29 | $3 | $36 |
| Application of on-body injector for under skin injection | 27 | $14 | $96 |
| Reticulated (young) platelet measurement | 26 | $35 | $143 |
| C-reactive protein test (inflammation marker) | 26 | $5 | $33 |
| Infusion into a vein for hydration, each additional hour | 25 | $10 | $75 |
| Irrigation of implanted venous access drug delivery device | 22 | $19 | $114 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 22 | $1 | $19 |
| Drawing of blood for a medical problem | 21 | $56 | $264 |
| Ct scan of abdomen with contrast | 16 | $116 | $793 |
| Haptoglobin (serum protein) level | 16 | $12 | $66 |
| Immunologic analysis technique on serum (immunofixation) | 16 | $22 | $160 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 16 | $178 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.9% high complexity
54.3% medium
10.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,521
Total received (2018-2024)
Avg $1,503/year across 7 years
Top 8% in TX for internal medicine
58
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,718 (63.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,222 (30.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$581 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,896
2023
$519
2022
$380
2021
$113
2020
$866
2019
$3,864
2018
$882
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,900
Novartis Pharmaceuticals Corporation
$439
Takeda Pharmaceuticals U.S.A., Inc.
$405
Amgen Inc.
$398
Janssen Biotech, Inc.
$317
Astellas Pharma US Inc
$301
Exelixis Inc.
$286
Incyte Corporation
$281
GENZYME CORPORATION
$275
E.R. Squibb & Sons, L.L.C.
$229
Genentech USA, Inc.
$210
PFIZER INC.
$204
AbbVie, Inc.
$198
Lilly USA, LLC
$189
Tempus AI, Inc
$179
Gilead Sciences, Inc.
$156
Merck Sharp & Dohme Corporation
$151
Ipsen Biopharmaceuticals, Inc
$137
Karyopharm Therapeutics Inc.
$131
Celgene Corporation
$128
Rigel Pharmaceuticals, Inc.
$127
Genmab U.S., Inc.
$125
ImmunoGen, Inc.
$125
Agios Pharmaceuticals, Inc.
$122
Myriad Genetic Laboratories, Inc.
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$115
Merck Sharp & Dohme LLC
$101
JAZZ PHARMACEUTICALS INC.
$93
Helsinn Therapeutics (U.S.), Inc.
$71
Janssen Pharmaceuticals, Inc
$69
Alexion Pharmaceuticals, Inc.
$66
Daiichi Sankyo Inc.
$62
TESARO, Inc.
$60
EISAI INC.
$59
TerSera Therapeutics LLC
$49
Regeneron Healthcare Solutions, Inc.
$46
AMAG Pharmaceuticals, Inc.
$45
Jazz Pharmaceuticals Inc.
$45
ABBVIE INC.
$45
Seattle Genetics, Inc.
$40
Taiho Oncology, Inc.
$40
Puma Biotechnology, Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$31
Apellis Pharmaceuticals, Inc.
$30
EMD Serono, Inc.
$29
Seagen Inc.
$29
Clovis Oncology, Inc.
$26
TOLMAR Pharmaceuticals, Inc.
$25
GlaxoSmithKline, LLC.
$24
Spectrum Pharmaceuticals Inc.
$24
Boston Scientific Corporation
$23
ARRAY BIOPHARMA INC
$21
Fennec Pharmaceuticals, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$17
Medtronic USA, Inc.
$15
Blueprint Medicines Corporation
$14
Advanced Accelerator Applications
$12
Secura Bio, Inc.
$9
Top 3 companies account for 45.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · AUBAGIO · AYVAKIT · Abraxane · Alecensa · BOSULIF · Balversa · Bavencio · CABLIVI · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · ELIGARD · ELITEK · EMEND · EMPLICITI · ERBITUX · ERLEADA · EXKIVITY · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · Folotyn · GAZYVA · GILOTRIF · HEMLIBRA · IBRANCE · IMFINZI · INLYTA · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nplate · OPDIVO · OSTEOCOOL RF ABLATION · Onivyde · PADCEV · PROMACTA · Pedmark · Perjeta · Pomalyst · RETEVMO · RYDAPT · Revlimid · Rubraca · SARCLISA · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VYXEOS · Vectibix · Venclexta · WaveWriter Alpha Prime 16 · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in TX.
Equivalent to $12 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
1,145
Per 100K population
56.2
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Crawley is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement in the top 8% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Crawley experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Crawley performed 25,500 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crawley receive payments from pharmaceutical companies?
Yes. Dr. Crawley received a total of $10,521 from 58 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crawley's costs compare to other internal medicine physicians in San Antonio?
Dr. Crawley's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crawley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in San Antonio
Browse internal medicine physicians in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology